Wells Fargo & Company MN lessened its stake in shares of STAAR Surgical Company (NASDAQ:STAA) by 21.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 52,912 shares of the medical instruments supplier’s stock after selling 14,350 shares during the period. Wells Fargo & Company MN owned 0.13% of STAAR Surgical worth $572,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in STAAR Surgical by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,272,972 shares of the medical instruments supplier’s stock worth $12,475,000 after acquiring an additional 18,621 shares during the period. Principal Financial Group Inc. increased its stake in shares of STAAR Surgical by 1.2% in the 2nd quarter. Principal Financial Group Inc. now owns 298,723 shares of the medical instruments supplier’s stock valued at $3,226,000 after purchasing an additional 3,594 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of STAAR Surgical by 6.3% in the 1st quarter. Geode Capital Management LLC now owns 245,080 shares of the medical instruments supplier’s stock valued at $2,401,000 after purchasing an additional 14,420 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of STAAR Surgical by 0.9% in the 1st quarter. Bank of New York Mellon Corp now owns 160,186 shares of the medical instruments supplier’s stock valued at $1,569,000 after purchasing an additional 1,392 shares during the last quarter. Finally, Renaissance Technologies LLC increased its stake in shares of STAAR Surgical by 18.6% in the 1st quarter. Renaissance Technologies LLC now owns 144,300 shares of the medical instruments supplier’s stock valued at $1,414,000 after purchasing an additional 22,600 shares during the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.

STAA has been the topic of several recent analyst reports. Zacks Investment Research upgraded STAAR Surgical from a “hold” rating to a “buy” rating and set a $12.00 price target on the stock in a research note on Saturday, September 23rd. BidaskClub upgraded STAAR Surgical from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Canaccord Genuity reiterated a “buy” rating and issued a $15.00 price target on shares of STAAR Surgical in a research note on Sunday, October 8th. Benchmark Co. lifted their price target on STAAR Surgical from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Friday, October 20th. Finally, TheStreet upgraded STAAR Surgical from a “d+” rating to a “c” rating in a research note on Tuesday, August 15th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $14.00.

COPYRIGHT VIOLATION NOTICE: “Wells Fargo & Company MN Sells 14,350 Shares of STAAR Surgical Company (STAA)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/11/12/wells-fargo-company-mn-sells-14350-shares-of-staar-surgical-company-staa.html.

STAAR Surgical Company (STAA) opened at $14.95 on Friday. STAAR Surgical Company has a 52 week low of $8.95 and a 52 week high of $15.80. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.81 and a current ratio of 2.24.

STAAR Surgical Company Profile

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical Company (NASDAQ:STAA).

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

Receive News & Stock Ratings for STAAR Surgical Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical Company and related stocks with our FREE daily email newsletter.